WallStSmart

HNI Corp (HNI)vsKewaunee Scientific Corporation (KEQU)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HNI Corp generates 1457% more annual revenue ($4.39B vs $282.00M). KEQU leads profitability with a 3.4% profit margin vs 0.1%. HNI earns a higher WallStSmart Score of 60/100 (C+).

HNI

Buy

60

out of 100

Grade: C+

Growth: 6.0Profit: 5.0Value: 6.3Quality: 4.5
Piotroski: 3/9Altman Z: 1.26

KEQU

Hold

38

out of 100

Grade: F

Growth: 3.3Profit: 6.0Value: 5.7Quality: 7.5
Piotroski: 3/9Altman Z: 3.28
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HNIUndervalued (+7.8%)

Margin of Safety

+7.8%

Fair Value

$56.12

Current Price

$46.87

$9.25 discount

UndervaluedFair: $56.12Overvalued
KEQUSignificantly Overvalued (-18.1%)

Margin of Safety

-18.1%

Fair Value

$33.69

Current Price

$34.45

$0.76 premium

UndervaluedFair: $33.69Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HNI3 strengths · Avg: 8.7/10
Revenue GrowthGrowth
120.7%10/10

Revenue surging 120.7% year-over-year

PEG RatioValuation
0.518/10

Growing faster than its price suggests

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

KEQU3 strengths · Avg: 10.0/10
P/E RatioValuation
11.4x10/10

Attractively priced relative to earnings

Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
3.2810/10

Safe zone — low bankruptcy risk

Areas to Watch

HNI4 concerns · Avg: 2.8/10
Return on EquityProfitability
0.1%3/10

ROE of 0.1% — below average capital efficiency

Profit MarginProfitability
0.1%3/10

0.1% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-31.5%2/10

Earnings declined 31.5%

KEQU4 concerns · Avg: 2.8/10
Market CapQuality
$105.56M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
3.4%3/10

3.4% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-7.5%2/10

Revenue declined 7.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : HNI

The strongest argument for HNI centers on Revenue Growth, PEG Ratio, Price/Book. Revenue growth of 120.7% demonstrates continued momentum. PEG of 0.51 suggests the stock is reasonably priced for its growth.

Bull Case : KEQU

The strongest argument for KEQU centers on P/E Ratio, Price/Book, Altman Z-Score.

Bear Case : HNI

The primary concerns for HNI are Return on Equity, Profit Margin, Piotroski F-Score. Thin 0.1% margins leave little buffer for downturns.

Bear Case : KEQU

The primary concerns for KEQU are Market Cap, Profit Margin, Piotroski F-Score. Thin 3.4% margins leave little buffer for downturns.

Key Dynamics to Monitor

HNI profiles as a hypergrowth stock while KEQU is a value play — different risk/reward profiles.

HNI carries more volatility with a beta of 0.91 — expect wider price swings.

HNI is growing revenue faster at 120.7% — sustainability is the question.

KEQU generates stronger free cash flow (5M), providing more financial flexibility.

Bottom Line

HNI scores higher overall (60/100 vs 38/100) and 120.7% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HNI Corp

CONSUMER CYCLICAL · FURNISHINGS, FIXTURES & APPLIANCES · USA

HNI Corporation manufactures and sells workplace furniture and residential construction products in the United States, Canada, China, Hong Kong, India, Mexico, Dubai, Taiwan, and Singapore. The company is headquartered in Muscatine, Iowa.

Kewaunee Scientific Corporation

CONSUMER CYCLICAL · FURNISHINGS, FIXTURES & APPLIANCES · USA

Kewaunee Scientific Corporation designs, manufactures and installs laboratory, sanitary and technical furniture products. The company is headquartered in Statesville, North Carolina.

Want to dig deeper into these stocks?